Breast Implant Market, By Product Type (Silicone Breast Implants, and Saline Breast Implants), By Application (Reconstructive Surgery, and Cosmetic Surgery), and By End-User (Hospitals, Cosmetology Clinics, and Others), Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028

pa_user-types

Check Today's Best Price

$3500 Buy Now
The global Breast Implant market size is estimated at 5.2 billion USD with a CAGR of 10.2% during the forecasted period from 2021-2028.
  • Market Overview

    The global Breast Implant market size is estimated at 5.2 billion USD with a CAGR of 10.2% during the forecasted period from 2021-2028.

    A medical prosthesis that is laid in the breast to enlarge, restructure, or make the physical form of the breast is referred to Breast Implant. There are mainly three types of breast implants namely saline implants, silicone gel-filled implants and alternative composite implants. The breast implant market is witnessing a large upsurge across the globe.

    The key factor driving the growth of this market is attributed to rise in occurrence of breast cancer across the globe. Also, mounting demand for breast surgeries is expanding this market. In addition, growing awareness regarding reconstructive breast surgeries is expected to fuel the market. Likewise, increasing healthcare expenditure with well established healthcare sector in developed nations is supporting the market growth.

    Moreover, high tech innovations in designs & construction of breast implants along with increasing research & development activities is fostering the market size. Furthermore, rise in disposable income with increasing medical tourism will accelerate the breast implant market size. Besides, increasing influence of social media accompanied by changing trend towards physical appearanceof breast is positively impacting the demand for breast implants.

    On the other hand, high cost is one of the major factors to limit the growth of global Breast Implant market. Also, lack of skilled healthcare personnel in developing economies can pose a challenge to the growth of this market.

    Market Driver

    Increase in breast cancer cases, and beauty consciousness is boosting the breast implant market. For instance, according to the World Cancer Research Fund International, there were over 2 million new cases of breast cancer in 2018. According to the American Society of Clinical Oncology (ASCO), in 2019, an estimate of 42,260 people (41,760 women and 500 men) will be dead from breast cancer.

    According to the American Society of Plastic Surgeons (ASPS), the Breast augmentation procedures have increased to 300,378, which is 3% from 2016. In 2017 patients who underwent breast reconstruction, 46% of women with silicone gel implants and 21% of those with saline implants.

    According to Institute of Medicine (IOM), 2015, nearly 280,000 women and teenagers underwent surgery to have their breasts enlarged with silicone or saline implants, and about 106,000 breast cancer patients had reconstruction after mastectomy, often with implants.

    Market Restraint

    The increasing side effects of breast implant cases might hamper the global breast implant market. For instance, the breast implant has certain side-effects, such as implant rupture, wrinkling, bleeding, asymmetry, anaesthesia reaction, scarring, pain, and infection. These complications occur at least 1% of breast implant patients. Around 20% of women who decide to have breast implant surgery have removed them within 8 to 10 years. The companies are withdrawing the sale of breast implant. For instance, in December 2018, Allergan plc has suspended sales of textured breast implants and tissue expanders and is withdrawing any remaining supply in European markets. The withdrawal decision follows a compulsory recall request from Agence Nationale de Sécurité du Médicament (ANSM), the French regulatory authority.

    Segment Analysis

    Based on Product Type, the global Breast Implant market is broadly segmented as Silicone Breast Implants, and Saline Breast Implants. In 2018 Silicone Breast Implants is the dominant segment, and it accounts for approximately 85% of the market.

    Silicone breast implants are filled with silicone gel. The gel feels a bit more like natural breast tissue. When the implant leaks, the gel may remain within the implant shell or may escape into the breast implant pocket. A leaking implant filled with silicone gel will not collapse. Silicone breast implants are FDA-approved for augmentation in women age 22 or older.

    The increasing regulatory approval for silicone breast implant is boosting the global breast implant market. For instance, in May 2017, Mentor Worldwide LLC, a global leader in breast aesthetics, have received the U.S. Food & Drug Administration (FDA) approval to market MemoryGel Xtra silicone gel-filled breast implants in the U.S. offers extra fullness and projection to women undergoing breast reconstruction, augmentation or revision surgery. Moreover, in January 2017, Allergan plc has received the U.S. Food and Drug Administration (FDA) approval to market NATRELLE INSPIRA SoftTouch breast implants, offering women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel, or cohesive, implant option. The company also have received the U.S. Food and Drug Administration (FDA) approval to market NATRELLE INSPIRA Cohesive breast implants. The new NATRELLE INSPIRA Cohesive line of breast implants is referred to as “gummy” implants, designed for women. Additionally, in December 2016, Sientra, Inc., a medical aesthetics company, have received U.S. Food and Drug Administration (FDA) pre-market supplement approval (PMA) for four new Silicone Breast Implant styles in both shaped and round as well as additional profile and sizing options for nine existing implant offerings.

    Breast Implant Market by- end user 2018

    Regional Analysis

    The global Breast Implant market is segmented into North America, Europe, Asia-Pacific, South America, Middle East & Africa.

    North America is dominating the global Breast Implant market, due to the increasing cosmetic surgeries for breast augmentation. For instance, in 2017, the total cosmetic surgical procedures for Breast augmentation in North America is around 333378. According to the American Society of Plastic Surgeons, Breast implants are used in nearly 100,000 reconstructions for breast cancer and 300,000 augmentations annually in the United States. In 2017, 110,344 breast augmentation procedures performed in Mexico. In 2015 Approximately 57,552 breast implant procedures were performed, which entirely comprises of silicone implants.

    The FDA approved saline-filled breast implants for women aged 18 years.   Only three companies have FDA approval to market saline implants in the US. Allergan and Mentor received FDA approval in 2000, and Ideal Implant received FDA approval in November 2014.

    The increasing cost of breast implant might hamper the North America breast implant market. For instance, In Canada breast implants for augmentation costs USD 5,000, and the replacement or removal operations cost USD 15,000. Add in the MRI tests to determine whether silicone implants are leaking cost additional USD 2,000 to USD 3,000.

    The North America Breast Implant market size was XX million USD in 2018, and it will be 871.6 million USD in 2025, with a CAGR 6.2% from 2019 to 2025.

    Europe is the second largest market for Breast implant due to the increasing cosmetic surgeries for breast augmentation. For instance, in 2016, the number of breast augmentation in Germany comprised of 46,627. Around 8,000 people have breast augmentation surgery each year in Britain. According to the NHS, in 2017, there were 8251 breast enlargements, increased from 7769 the previous year. The case of Anaplastic large cell lymphoma (ALCL) due to breast implant in Europe might hamper the market. For instance, The Medicines and Healthcare Products Regulatory Authority (MHRA) has received 25 adverse incident reports of anaplastic large cell lymphoma (ALCL) in women with breast implants up to June 2017. 25 cases of ALCL in women with breast implants reported to MHRA two patient deaths have been reported

    Competitive Analysis

    The major players include Allergan Plc, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics PLC, POLYTECH Health & Aesthetics GmbH, Hansbiomed Co. Ltd., Ideal Implant Incorporated, Guangzhou Wanhe Plastic Materials Co., Ltd., Establishment Labs S.A., and Groupe Sebbin SAS.

    The strategic agreement between companies to develop breast implant is boosting the global Breast Implant market. For instance, in April 2018, Ideal Implant Incorporated has received FDA approval to manufacture their Structured Breast Implant at Vesta, a Lubrizol LifeSciences company and a leading medical device contract manufacturer of silicone products and other medical devices. Moreover, in April 2018 Sientra, Inc. a medical aesthetics company, have received U.S. Food and Drug Administration (FDA) approval of the Company’s PMA supplement allowing commercialization of its OPUS-branded breast implant products manufactured by Vesta, a Lubrizol LifeSciences company, at Vesta’s Wisconsin-based manufacturing facility. Additionally, in August 2016, Sientra has entered into a services agreement with Vesta for manufacturing of breast implants. Vesta establishes manufacturing capacity for Sientra, a medical aesthetics company, and is working to finalize a long-term supply agreement for Sientra’s PMA-approved breast implants.

    Global Breast Implant Market

    • Consumption by Regions
      • North America
      • Europe
      • South America
      • Asia Pacific
      • The Middle East and Africa
    • Segment by Type
      • Silicone Breast Implants
      • Saline Breast Implants
    • Segment by Application
      • Reconstructive Surgery
      • Cosmetic Surgery
    • Segment by End User
      • Hospitals
      • Cosmetology Clinics
      • Others
    keyboard_arrow_up
  • Table of Content

    1. Market Introduction
    1.1. Executive Summary
    1.2. Market Definition
    1.3. Market Scope

    2. Research Methodology
    2.1. Primary Research
    2.2. Research Methodology
    2.3. Assumptions & Exclusions
    2.4. Secondary data sources

    3. Breast Implant Market Overview
    3.1. Report Segmentation & Scope
    3.2. Key Market Trend
    3.3. Drivers
    3.3.1. Rising incidence of breast cancer
    3.3.2. A growing number of breast augmentation procedures
    3.4. Restraints
    3.4.1. The high cost of the implant procedure
    3.4.2. Post-surgical complications
    3.5. Opportunity
    3.5.1. Introduction of technologically advanced products
    3.6. Porter’s Five Forces Analysis
    3.6.1. Porter’s Five Forces Analysis
    3.7. Market Share Analysis

    4. Product Type Overview
    4.1. Introduction
    4.1.1. Market Size & Forecast
    4.2. Silicone Breast Implants
    4.2.1. Market Size & Forecast
    4.3. Saline Breast Implants
    4.3.1. Market Size & Forecast

    5. Application Overview
    5.1. Introduction
    5.1.1. Market Size & Forecast
    5.2. Reconstructive Surgery
    5.2.1. Market Size & Forecast
    5.3. Cosmetic Surgery
    5.3.1. Market Size & Forecast

    6. End-User Overview
    6.1. Introduction
    6.1.1. Market Size & Forecast
    6.2. Hospitals
    6.2.1. Market Size & Forecast
    6.3. Cosmetology Clinics
    6.3.1. Market Size & Forecast
    6.4. Others
    6.4.1. Market Size & Forecast

    7. Breast Implant Market Regional Overview
    7.1. Introduction
    7.1.1. Market Size & Forecast
    7.2. North America Breast Implant Market
    7.2.1. North America Market Size & Forecast, By Country
    7.2.2. North America Market Size & Forecast, By Product Type
    7.2.3. North America Market Size & Forecast, By Application
    7.2.4. North America Market Size & Forecast, By End-User
    7.2.5. The U.S.
    7.2.5.1. Market Size and Forecast
    7.2.6. Canada
    7.2.6.1. Market Size and Forecast
    7.2.7. Mexico
    7.2.7.1. Market Size and Forecast
    7.3. Europe Breast Implant Market
    7.3.1. Europe Market Size & Forecast, By Country
    7.3.2. Europe Market Size & Forecast, By Product Type
    7.3.3. Europe Market Size & Forecast, By Application
    7.3.4. Europe Market Size & Forecast, By End-User
    7.3.5. Germany
    7.3.5.1. Market Size and Forecast
    7.3.6. France
    7.3.6.1. Market Size and Forecast
    7.3.7. UK
    7.3.7.1. Market Size and Forecast
    7.3.8. Italy
    7.3.8.1. Market Size and Forecast
    7.3.9. Spain
    7.3.9.1. Market Size and Forecast
    7.3.10. Rest of Europe
    7.3.10.1. Market Size and Forecast
    7.4. Asia-Pacific Breast Implant Market
    7.4.1. Asia-Pacific Market Size & Forecast, By Country
    7.4.2. Asia-Pacific Market Size & Forecast, By Product Type
    7.4.3. Asia-Pacific Market Size & Forecast, By Application
    7.4.4. Asia-Pacific Market Size & Forecast, By End-User
    7.4.5. Japan
    7.4.5.1. Market Size and Forecast
    7.4.6. China
    7.4.6.1. Market Size and Forecast
    7.4.7. Australia
    7.4.7.1. Market Size and Forecast
    7.4.8. India
    7.4.8.1. Market Size and Forecast
    7.4.9. South Korea
    7.4.9.1. Market Size and Forecast
    7.4.10. Rest of Asia-Pacific
    7.4.10.1. Market Size and Forecast
    7.5. Rest of the World Breast Implant Market
    7.5.1. Rest of the World Market Size & Forecast, By Country
    7.5.2. Rest of the World Market Size & Forecast, By Product Type
    7.5.3. Rest of the World Market Size & Forecast, By Application
    7.5.4. Rest of the World Market Size & Forecast, By End-User
    7.5.5. South America
    7.5.5.1. Market Size and Forecast
    7.5.6. Middle East
    7.5.6.1. Market Size and Forecast
    7.5.7. Africa
    7.5.7.1. Market Size and Forecast

    8. Company Profile
    8.1. Allergan Plc
    8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    8.1.2. Allergan Plc Product Category, Application, and Specification
    8.1.3. Allergan Plc Financial Performance (2016-2018)
    8.1.4. Main Business/Business Overview
    8.2. Mentor Worldwide LLC (Johnson & Johnson)
    8.3. Sientra Inc.
    8.4. GC Aesthetics PLC
    8.5. POLYTECH Health & Aesthetics GmbH
    8.6. Hansbiomed Co. Ltd.
    8.7. Ideal Implant Incorporated
    8.8. Guangzhou Wanhe Plastic Materials Co., Ltd.
    8.9. Establishment Labs S.A.
    8.10. Groupe Sebbin SAS

    keyboard_arrow_up
    • The following manufacturers are covered:
      • Allergan Plc
      • Mentor Worldwide LLC (Johnson & Johnson)
      • Sientra Inc.
      • GC Aesthetics PLC
      • POLYTECH Health & Aesthetics GmbH
      • Hansbiomed Co. Ltd.
      • Ideal Implant Incorporated
      • Guangzhou Wanhe Plastic Materials Co., Ltd.
      • Establishment Labs S.A.
      • Groupe Sebbin SAS
    keyboard_arrow_up


      • Keep your personal detail safe with us. Privacy Policy
        This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    CLIENTS

    SHARE YOUR CART